GEORGE A SCANGOS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEORGE A SCANGOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEORGE A SCANGOS. GEORGE A SCANGOS is an Chief Executive Officer in BIOGEN INC. ($IDPH) and a Director in AGILENT TECHNOLOGIES INC ($A) and a Director in EXELIXIS, INC. ($EXEL) and a President and CEO in Vir Biotechnology, Inc. ($VIR).
Companies in which GEORGE A SCANGOS is an Insider
AGILENT TECHNOLOGIES, INC.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of GEORGE A SCANGOS: Director
Holdings: 15,558 shares
Current Value: $772,299
Latest Transaction: Mar 22 2021
$A Market Capitalization: $16.06B
$A Previous Close: $49.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEORGE A SCANGOS: Chief Executive Officer
Holdings: 54,779 shares
Latest Transaction: Jul 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXELIXIS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEORGE A SCANGOS: Director
Holdings: 714,717 shares
Current Value: $14,701,729
Latest Transaction: May 20 2020
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vir Biotechnology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEORGE A SCANGOS: President and CEO
Holdings: 4,609,559 shares
Latest Transaction: Feb 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GEORGE A SCANGOS
Sentiment: All, A, IDPH, EXEL, VIR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 121.59 | 986 | 119,891 | 16,544 | 15.6 K to 16.5 K (+6.34 %) |
| Mar 22 2021 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 121.59 | 1,850 | 224,947 | 15,558 | 13.7 K to 15.6 K (+13.50 %) |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Option Exercise | A | 67.38 | 222,000 | 14,958,360 | 222,000 | |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Grant | A | 0.00 | 111,000 | 0 | 4,609,559 | 4.5 M to 4.6 M (+2.47 %) |
| Aug 05 2020 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 93.91 | 177 | 16,622 | 28,112 | 27.9 K to 28.1 K (+0.63 %) |
| May 20 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.96 | 75,000 | 1,947,000 | 714,717 | 789.7 K to 714.7 K (-9.50 %) |
| May 15 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 5.82 | 21,686 | 126,213 | 0 |